CELLULAR LATENCY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS WITH HIGH CD4 LEVELS CAN BE DETECTED BY THE PRESENCE OF PROMOTER-PROXIMAL TRANSCRIPTS

被引:141
作者
ADAMS, M
SHARMEEN, L
KIMPTON, J
ROMEO, JM
GARCIA, JV
PETERLIN, BM
GROUDINE, M
EMERMAN, M
机构
[1] FRED HUTCHINSON CANC RES CTR, PROGRAM MOLEC MED, SEATTLE, WA 98104 USA
[2] UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT MED, SAN FRANCISCO, CA 94143 USA
[3] UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT MICROBIOL, SAN FRANCISCO, CA 94143 USA
[4] UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT IMMUNOL, SAN FRANCISCO, CA 94143 USA
[5] UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT LAB MED, SAN FRANCISCO, CA 94143 USA
[6] FRED HUTCHINSON CANC RES CTR, DIV BASIC SCI, SEATTLE, WA 98104 USA
[7] ST JUDE CHILDRENS RES HOSP, DEPT VIROL & MOLEC BIOL, MEMPHIS, TN 38105 USA
关键词
AIDS; TAT; TRANSCRIPTION ELONGATION; U1; CELLS;
D O I
10.1073/pnas.91.9.3862
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We have investigated the molecular basis of human immunodeficiency virus type 1 (HIV-1) latency in a tissue culture model and in HIV-infected people. We show that increased levels of Tat, but not Rev, can release the proviruses from latency in U1 cells. The absence of Tat in these cells is manifested by the accumulation of promoter-proximal viral transcripts, whereas the presence of Tat correlates with increased expression of viral proteins and an increase in promoter-distal transcripts. The presence of promoter-proximal transcripts also serves as a marker for latency in humans. We observed the exclusive presence of promoter-proximal viral transcripts ire peripheral mononuclear cells from the majority (10/11) of asymptomatic HIV-infected individuals examined. Activation of these cells in vitro, and viremia in vivo, correlated with a switch from promoter-proximal transcription to promoter-distal transcription. These results suggest that the control between latency and replication of HIV in vivo is at the level of transcription elongation.
引用
收藏
页码:3862 / 3866
页数:5
相关论文
共 31 条
  • [1] MOLECULAR PROFILE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN SYMPTOMLESS PATIENTS AND IN PATIENTS WITH AIDS
    BAGNARELLI, P
    MENZO, S
    VALENZA, A
    MANZIN, A
    GIACCA, M
    ANCARANI, F
    SCALISE, G
    VARALDO, PE
    CLEMENTI, M
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (12) : 7328 - 7335
  • [2] MECHANISMS OF HIV-1 LATENCY
    BEDNARIK, DP
    FOLKS, TM
    [J]. AIDS, 1992, 6 (01) : 3 - 16
  • [3] QUIESCENT LYMPHOCYTES-T AS AN INDUCIBLE VIRUS RESERVOIR IN HIV-1 INFECTION
    BUKRINSKY, MI
    STANWICK, TL
    DEMPSEY, MP
    STEVENSON, M
    [J]. SCIENCE, 1991, 254 (5030) : 423 - 427
  • [4] PLASMA VIREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION
    COOMBS, RW
    COLLIER, AC
    ALLAIN, JP
    NIKORA, B
    LEUTHER, M
    GJERSET, GF
    COREY, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) : 1626 - 1631
  • [5] MASSIVE COVERT INFECTION OF HELPER T-LYMPHOCYTES AND MACROPHAGES BY HIV DURING THE INCUBATION PERIOD OF AIDS
    EMBRETSON, J
    ZUPANCIC, M
    RIBAS, JL
    BURKE, A
    RACZ, P
    TENNERRACZ, K
    HAASE, AT
    [J]. NATURE, 1993, 362 (6418) : 359 - 362
  • [6] MULTIFACTORIAL NATURE OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE - IMPLICATIONS FOR THERAPY
    FAUCI, AS
    [J]. SCIENCE, 1993, 262 (5136) : 1011 - 1018
  • [7] THE ROLE OF TAT IN THE HUMAN-IMMUNODEFICIENCY-VIRUS LIFE-CYCLE INDICATES A PRIMARY EFFECT ON TRANSCRIPTIONAL ELONGATION
    FEINBERG, MB
    BALTIMORE, D
    FRANKEL, AD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (09) : 4045 - 4049
  • [8] FOLKS TM, 1988, J IMMUNOL, V140, P1117
  • [9] RETROVIRUS VECTOR-MEDIATED TRANSFER OF FUNCTIONAL HIV-1 REGULATORY GENES
    GARCIA, JV
    MILLER, AD
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (01) : 47 - 52
  • [10] QUANTITATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 IN THE BLOOD OF INFECTED PERSONS
    HO, DD
    MOUDGIL, T
    ALAM, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) : 1621 - 1625